On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
The union representing thousands of Minnesota nurses said on Tuesday it had reached a tentative agreement with hospitals on a new contract that, if approved by members, would resolve a labor dispute without a threatened strike.
The U.S. military has no hard data to back up claims by top Republicans in Congress that the Pentagon's COVID-19 vaccine mandate is hurting recruiting, Defense Secretary Lloyd Austin said on Tuesday.
Chile's government launched an investigation on Tuesday after raspberries from a Chilean company were recalled in the United States due to hepatitis A contamination.
Drugmakers GSK Plc , Pfizer Inc , Sanofi SA and Boehringer Ingelheim on Tuesday defeated thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.
India's premier government hospital in New Delhi which was hit by a cyber attack nearly two weeks ago that shut down servers and disrupted patient care has restored some server functionality, police and institute officials said.
Elon Musk's Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations amid internal staff complaints that its animal testing is being rushed, causing needless suffering and deaths.
Ukraine's health ministry said on Tuesday it was asking regional officials to consider suspending non-essential surgeries until the energy situation inside the country stabilizes.
The European Medicines Agency said on Tuesday its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults.
Contract drugmaker Emergent Biosolutions said on Tuesday its over-the-counter nasal spray as a treatment for suspected opioid overdose would be reviewed on a priority basis by the U.S. health regulator.
France's ANSM national drug agency said it is under formal investigation on suspicion of issuing misleading information regarding German drugmaker Merck's thyroid drug Levothyrox, adding it contested the provisional charges.
